Moore MJ - Search Results

1

A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer.

Aglietta M, Barone C, Sawyer MB, Moore MJ, Miller WH Jr, Bagalà C, Colombi F, Cagnazzo C, Gioeni L, Wang E, Huang B, Fly KD, Leone F. Aglietta M, et al. Among authors: moore mj. Ann Oncol. 2014 Sep;25(9):1750-1755. doi: 10.1093/annonc/mdu205. Epub 2014 Jun 6. Ann Oncol. 2014. PMID: 24907635 Free article. Clinical Trial.

2

Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.

Moore MJ, Osoba D, Murphy K, Tannock IF, Armitage A, Findlay B, Coppin C, Neville A, Venner P, Wilson J. Moore MJ, et al. J Clin Oncol. 1994 Apr;12(4):689-94. doi: 10.1200/JCO.1994.12.4.689. J Clin Oncol. 1994. PMID: 7512127 Clinical Trial.

3

Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group.

Mertens WC, Eisenhauer EA, Jolivet J, Ernst S, Moore M, Muldal A. Mertens WC, et al. Ann Oncol. 1994 Feb;5(2):185-7. doi: 10.1093/oxfordjournals.annonc.a058776. Ann Oncol. 1994. PMID: 7910480 Free article. Clinical Trial.

4

A phase II study of 5-fluorouracil, leucovorin and interferon-alpha in advanced pancreatic cancer.

Moore MJ, Erlichman C, Kaizer L, Fine S. Moore MJ, et al. Anticancer Drugs. 1993 Oct;4(5):555-7. doi: 10.1097/00001813-199310000-00004. Anticancer Drugs. 1993. PMID: 8292812 Clinical Trial.

5

Multicenter phase II study of brequinar sodium in patients with advanced gastrointestinal cancer.

Moore M, Maroun J, Robert F, Natale R, Neidhart J, Dallaire B, Sisk R, Gyves J. Moore M, et al. Invest New Drugs. 1993 Feb;11(1):61-5. doi: 10.1007/BF00873913. Invest New Drugs. 1993. PMID: 8349438 Free article. Clinical Trial.

6

A phase II study of methotrexate, vinblastine, doxorubicin and cisplatin plus recombinant human granulocyte-macrophage colony stimulating factors in patients with advanced transitional cell carcinoma.

Moore MJ, Iscoe N, Tannock IF. Moore MJ, et al. J Urol. 1993 Oct;150(4):1131-4. doi: 10.1016/s0022-5347(17)35706-3. J Urol. 1993. PMID: 8371371 Clinical Trial.

7

Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.

Erlichman C, Moore M, Thiessen JJ, Kerr IG, Walker S, Goodman P, Bjarnason G, DeAngelis C, Bunting P. Erlichman C, et al. Cancer Res. 1993 Oct 15;53(20):4837-42. Cancer Res. 1993. PMID: 8402670 Clinical Trial.

8

Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group.

Mertens WC, Eisenhauer EA, Moore M, Venner P, Stewart D, Muldal A, Wong D. Mertens WC, et al. Ann Oncol. 1993 Apr;4(4):331-2. doi: 10.1093/oxfordjournals.annonc.a058494. Ann Oncol. 1993. PMID: 8518225 Free article. Clinical Trial.

9

A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma.

Hsue V, Wong CS, Moore M, Erlichman C, Cummings BJ, MacLeod M. Hsue V, et al. Int J Radiat Oncol Biol Phys. 1996 Jan 15;34(2):445-50. doi: 10.1016/0360-3016(95)02032-2. Int J Radiat Oncol Biol Phys. 1996. PMID: 8567347 Clinical Trial.

10

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

Tannock IF, Osoba D, Stockler MR, Ernst DS, Neville AJ, Moore MJ, Armitage GR, Wilson JJ, Venner PM, Coppin CM, Murphy KC. Tannock IF, et al. Among authors: moore mj. J Clin Oncol. 1996 Jun;14(6):1756-64. doi: 10.1200/JCO.1996.14.6.1756. J Clin Oncol. 1996. PMID: 8656243 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

798 results

Search Page